Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial

Published:2024-06 Issue: Volume: Page:
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Helget Lindsay N.,Davis-Karim Anne,O’Dell James R.,Mikuls Ted R.,Newcomb Jeff A.,Androsenko Maria,Brophy Mary T.,England Bryant R.,Ferguson Ryan,Pillinger Michael H.,Neogi Tuhina,Wu Hongsheng,Palevsky Paul M.

Funder

US Department of Veterans Affairs

Publisher

Elsevier BV

Reference22 articles.

1. 2020 American College of Rheumatology Guideline for the Management of Gout;FitzGerald;Arthritis Care Res (Hoboken),2020

2. 2016 Updated EULAR evidence-based recommendations for the management of gout;Richette;Ann Rheum Dis,2017

3. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany;Van den Bussche;BMC Public Health,2011

4. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008;Zhu;Am J Med,2012

5. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012;Ramasamy;Drug Saf,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD;American Journal of Kidney Diseases;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP